Portfolio company
Intersect ENT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company manufactures drug-eluting sinus implants for patients with chronic rhinosinusitis and healthcare professionals in the ear, nose and throat sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aerin Medical
This company develops non-invasive radiofrequency devices for ear, nose and throat physicians to treat patients with nasal airway obstruction and chronic rhinitis.
Intrinsic Therapeutics
This company manufactures spinal implants for surgeons to reduce the risk of recurring disc herniations in patients undergoing discectomy procedures.
SI-BONE
This company develops and sells implants and surgical systems for the treatment of musculoskeletal disorders in the sacropelvic anatomy for surgeons and hospitals.
Inspire Medical Systems
This company manufactures an implantable neurostimulation device for patients with moderate to severe obstructive sleep apnea who cannot benefit from continuous positive airway pressure.
Neurent Medical
This company develops radiofrequency ablation systems used by clinicians to treat chronic rhinitis by disrupting overactive nerves within the nasal cavity.
Tympanogen
This medical device company develops a gel patch for eardrum repair, selling to ear, nose and throat surgeons and outpatient clinics.
Intarcia Therapeutics
This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.
ArthroCare
This company develops radiofrequency-based surgical devices and implants for sports medicine, ear, nose, and throat procedures, and spinal treatments for healthcare professionals.
